Selecta
is a Massachusetts-based biotechnology company that researches and develops immunotherapies for the treatment of autoimmune diseases... Read moreSelecta
is a Massachusetts-based biotechnology company that researches and develops immunotherapies for the treatment of autoimmune diseases... Read more
CEO
Add
2007
PrivateMerged with Cartesian Therapeutics, Inc.
News
Sep 03, 2024
GlobeNewswire
Press Release: Selecta : Cartesian Therapeutics Announces First Patient Dosed in First-In-Human Phase 1 Trial of Next-Generation mRNA CAR-T Cell Therapy Descartes-15
May 09, 2024
Owler
Selecta Biosciences, Inc.: Selecta's revenue changed from $26M in Dec 2023 to $25.91M in Mar 2024
Mar 08, 2024
Owler
Selecta Biosciences, Inc.: Selecta's employee count changed from 64 in Dec 2022 to 76 in Dec 2023
Nov 15, 2023
Medthority
Selecta: Selecta Biosciences merges with Cartesian Therapeutics
Nov 13, 2023
Citybizlist
Selecta: Selecta Biosciences and Cartesian Therapeutics Merge
Nov 13, 2023
sec
Selecta: Selecta Biosciences Received $60.3M in Post-IPO Equity Funding
Nov 03, 2023
GlobalNewswire
Press Release: Selecta : INVESTOR ALERT: Abbott Cooper PLLC Announces Investigation into Selecta Biosciences, Inc.; Urges Selecta Stockholders to Contact Abbott Cooper Regarding Their Legal Rights
Oct 31, 2023
Marketscreener
Selecta: Selecta Announces Transition of Manufacturing and Clinical Operations of ImmTOR for SEL-212 to Commercialization Partner Sobi
Aug 20, 2023
Americanbankingnews
Selecta: Selecta Biosciences (NASDAQ:SELB) Announces Quarterly Earnings Results, Beats Estimates By $0.05 EPS
Aug 17, 2023
Marketscreener
Selecta: Selecta Biosciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Selecta Competitors
1
2
3
4
5
6
7
8
9
10